iHateHospitals.com

CANCER NEWS: Well, it has been a couple months since we posted anything here…..you know it really is true…life does go on! Valerie had implants put in last October, and with all the changes her body went through after Chemo and Radiation, they (the implants) have decided not to cooperate. So, Valerie is scheduled [...]

CANCER NEWS: Well, it has been a couple months since we posted anything here…..you know it really is true…life does go on! Valerie had implants put in last October, and with all the changes her body went through after Chemo and Radiation, they (the implants) have decided not to cooperate. So, Valerie is scheduled [...]

DRUGS & RX: PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)–Aug 26, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc (NYSE: PFE) provided an update on the apixaban clinical development program today. The companies announced that new Phase II data…

View the source of this article…

Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program [...]

DRUGS & RX: SOPHIA ANTIPOLIS, France, August 25, 2008 -NicOx S.A. (Euronext Paris: COX) today announced the results of a dose-ranging phase 2 study conducted with PF-03187207 in Japanese patients with glaucoma by its partner Pfizer Inc. PF-03187207 is a…

View the source of this article…

NicOx Provides Update on PF-03187207 and the Ongoing Research Collaboration with [...]

DRUGS & RX: Information for Healthcare Professionals Natalizumab Injection for Intraveneous Use (marketed as Tysabri)
ROCKVILLE, Md., Aug. 25, 2008–FDA ALERT [8/2008]: The FDA has recently received information from the manufacturer about two new cases of…

View the source of this article…

FDA Updates the Information for Healthcare Professionals Sheet for Tysabri (natalizumab) was another wonderful and informative [...]

DRUGS & RX: MIAMI–(BUSINESS WIRE)–Aug 25, 2008 - Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today provided an update on the status of Daytrana(R), the only transdermal patch indicated for the treatment of the symptoms of Attention Deficit Hyperactivity…

View the source of this article…

Noven Provides Update on Daytrana Methylphenidate Transdermal System was another wonderful and informative drug and [...]

VIOXX CLASS ACTION LAWSUIT UPDATE:
Partial settlement payments will soon be in the mail to those people who claim that taking Vioxx caused them to suffer heart attacks, the Associated Press is reporting. Vioxx is the pain reliever that was linked to heart failure and has since been removed from the market.  Payments are scheduled to [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: A Vioxx study that was supposedly meant to find out if the recalled painkiller was less likely to cause stomach problems than another drug was really nothing more than a marketing ploy, a new report says.   According to (Vioxx maker) Merck & Co. memos and reports obtained during Vioxx [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … Drug companies are spending millions of pounds every … 30 staff “to discuss drugs (don’t do drugs) for the treatment of breast cancer”. The trust’s register records … to unsafe prescribing of drugs (don’t do drugs) such as Vioxx, the arthritis drug which was [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … Wed., Mar. 12, 2008 re: So these drug selling thieves are collecting taxes from their … could crush them. Or a cop on medical marijuana with his gun drawn. People high … failed drug war. Rumsfeld profitted mightily from Vioxx and the bird [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … Wed., Mar. 12, 2008 re: So these drug selling thieves are collecting taxes from their … could crush them. Or a cop on medical marijuana with his gun drawn. People high … failed drug war. Rumsfeld profitted mightily from Vioxx and the bird [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … marketing and R&D inevitably overlap in the pharmaceutical business. ADVANTAGE was a randomized clinical trial, … “gold standard” research used to support new drug approvals and much else in healthcare practice. … name of Alleve. ADVANTAGE was started before Vioxx was approved for [...]